corbadrine has been researched along with phentolamine in 1 studies
Studies (corbadrine) | Trials (corbadrine) | Recent Studies (post-2010) (corbadrine) | Studies (phentolamine) | Trials (phentolamine) | Recent Studies (post-2010) (phentolamine) |
---|---|---|---|---|---|
20 | 0 | 12 | 9,141 | 270 | 265 |
Protein | Taxonomy | corbadrine (IC50) | phentolamine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.396 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.006 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 10 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.018 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.11 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0173 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.359 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.396 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0011 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0108 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.807 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.5495 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Timmermans, PB; van Zwieten, PA | 1 |
1 review(s) available for corbadrine and phentolamine
Article | Year |
---|---|
alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs.
Topics: Adipose Tissue; Animals; Blood Platelets; Central Nervous System; Humans; Islets of Langerhans; Melanocytes; Muscle, Smooth, Vascular; Nerve Endings; Norepinephrine; Parasympathetic Nervous System; Radioligand Assay; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Serotonin; Synapses | 1982 |